Date :
Place : United States, San Jose
Contact Person:Ashutos Swain
Description:
Data integrity has been a focus for pharmaceutical regulatory inspections for a number of years and look set to remain of concern to regulators and manufacturers for many years to come. Many inspection reports from regulatory agencies around the world cite data integrity as a cause of observations and enforcement action, and actions taken by regulators to restrict the commercial activities of manufacturers on the grounds of data integrity violations have obvious serious consequences for the company concerned.Deadline for abstracts/proposals : 10th January 2021
Organized By :Complianceonline
Keynote Speakers :
Check the event website for more details.